Literature DB >> 17446440

Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.

Emmanuel L Gautier1, Thierry Huby, Betty Ouzilleau, Chantal Doucet, Flora Saint-Charles, Guilaine Gremy, M John Chapman, Philippe Lesnik.   

Abstract

OBJECTIVE: Premature atherosclerosis is a characteristic feature of systemic lupus erythematosus, a prototypic autoimmune disease. The principle cellular and molecular mechanisms which underlie such accelerated atherosclerosis are indeterminate. METHODS AND
RESULTS: The pathophysiology of lupus-mediated atherogenesis was evaluated in a novel animal model involving transplantation of bone marrow cells from the lupus prone strain gld into Ldl-r(-/-) mice. Diet-induced atherogenesis in lethally-irradiated Ldl-r(-/-) mice transplanted with gld bone marrow cells resulted in accelerated atherosclerosis (+65%) as compared with control mice transplanted with wild-type marrow cells. Enhanced atherogenesis was associated with enhanced activation of both B and T lymphocytes and with arterial inflammation involving endothelial cell activation, monocyte recruitment, and accumulation of apoptotic debris, macrophages, and CD4 T cells, but was independent of plasma lipid levels and renal function.
CONCLUSIONS: Our data support the contention that despite the absence of both disturbed cholesterol homeostasis and renal dysfunction in autoimmune gld-->Ldl-r(-/-) mice, lupus disease induces enhanced activation of the immune system and acts locally on the vasculature to induce inflammation, together with accumulation of apoptotic debris, macrophages, and CD4 T cells, thereby accelerating plaque progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446440     DOI: 10.1161/ATVBAHA.107.142430

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Local apoptosis mediates clearance of macrophages from resolving inflammation in mice.

Authors:  Emmanuel L Gautier; Stoyan Ivanov; Philippe Lesnik; Gwendalyn J Randolph
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

2.  Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state.

Authors:  R Angelo de Claro; Xiaodong Zhu; Jingjing Tang; Vicki Morgan-Stevenson; Barbara R Schwartz; Akiko Iwata; W Conrad Liles; Elaine W Raines; John M Harlan
Journal:  Am J Pathol       Date:  2011-05-06       Impact factor: 4.307

3.  IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.

Authors:  Amanda A Watkins; Kei Yasuda; Gabriella E Wilson; Tamar Aprahamian; Yao Xie; Elena Maganto-Garcia; Prachi Shukla; Lillian Oberlander; Bari Laskow; Hanni Menn-Josephy; Yuanyuan Wu; Pierre Duffau; Susan K Fried; Andrew H Lichtman; Ramon G Bonegio; Ian R Rifkin
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

4.  Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.

Authors:  Seth G Thacker; Wenpu Zhao; Carolyne K Smith; Wei Luo; Hui Wang; Anuradha Vivekanandan-Giri; Bradley J Rabquer; Alisa E Koch; Subramaniam Pennathur; Anne Davidson; Daniel T Eitzman; Mariana J Kaplan
Journal:  Arthritis Rheum       Date:  2012-09

5.  Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

Review 6.  Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

7.  The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.

Authors:  N S Wade; B G Stevenson; D S Dunlap; A S Major
Journal:  Lupus       Date:  2009-10-22       Impact factor: 2.911

8.  17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice.

Authors:  K A Shelton; J M Cline; J A Cann
Journal:  Atherosclerosis       Date:  2013-01-18       Impact factor: 5.162

9.  Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.

Authors:  Allison B Reiss; Kamran Anwar; Joan T Merrill; Edwin S L Chan; Nahel W Awadallah; Bruce N Cronstein; H Michael Belmont; Elise Belilos; Gary Rosenblum; Kristina Belostocki; Lois Bonetti; Kowser Hasneen; Steven E Carsons
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

10.  Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity.

Authors:  Emmanuel L Gautier; Andrew Chow; Rainer Spanbroek; Genevieve Marcelin; Melanie Greter; Claudia Jakubzick; Milena Bogunovic; Marylene Leboeuf; Nico van Rooijen; Andreas J Habenicht; Miriam Merad; Gwendalyn J Randolph
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.